Schernthaner, Guntram
Karasik, Avraham
Abraitienė, Agnė
Ametov, Alexander S.
Gaàl, Zsolt
Gumprecht, Janusz
Janež, Andrej
Kaser, Susanne
Lalić, Katarina
Mankovsky, Boris N.
Moshkovich, Evgeny
Past, Marju
Prázný, Martin
Radulian, Gabriela
Smirčić Duvnjak, Lea
Tkáč, Ivan
Trušinskis, Kārlis
Article History
Received: 25 July 2019
Accepted: 21 August 2019
First Online: 31 August 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: GS has previously received research grants and honoraria for speaking from Abbot, Amgen, Andromeda, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, DeveloGen, Eli Lilly, GlaxoSmithKline, Janssen, Merck, MSD, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi-Aventis, Serono, Servier and Takeda. AK has received research support, lecture fees and served as advisory board member for Astra Zeneca, Boehringer Ingelheim and Novo Nordisk. ZG declares receipt of consultation fees from Novo Nordisk, Eli Lilly, Sanofi, Boehringer Ingelheim, AstraZeneca and MSD; and Advisory board fees from Sanofi, Novo Nordisk, and Eli Lilly. JG has received speaker’s or consulting honoraria from Novo Nordisk, Eli Lilly, Servier, MSD, Bioton (Poland), Sanofi, Polpharma (Poland), Polfa Tarchomin (Poland), AstraZeneca and Boehringer Ingelheim. AJ has served as a consultant and is on Speakers Bureaus for AstraZeneca, Boehringer Ingelheim, Eli Lilly, MSD, Novo Nordisk and Sanofi. SK declares research grants from MSD Austria and Boehringer Ingelheim RCV; consultancy fees or honoraria for speaking from AstraZeneca, Boehringer Ingelheim, MSD, Eli Lilly, Novo Nordisk, Sanofi, Takeda and Mundipharma. BNM has been a member of Advisory Boards for Boehringer Ingelheim and AstraZeneca; and a member of a speaker bureau for Boehringer Ingelheim, AstraZeneca and Sanofi. EM is a lecturer for Boehringer Ingelheim, AstraZeneca, Sanofi, Novo Nordisk, MSD and Eli Lilly. MP2 has been a consultant or speaker for Abbott, AstraZeneca, Boehringer Ingelheim, Dexcom, Eli Lilly, Medtronic, Novo Nordisk, Sanofi, Takeda and Teva. LSD declares receipt of consultation fees or participation in a company-sponsored speaker’s bureau for Novo Nordisk, Eli Lilly, Sanofi, Boehringer Ingelheim, AstraZeneca, Takeda, MSD and Merck. IT declares consultation and lecture fees from Boehringer Ingelheim, Eli Lilly, Mundipharma and Novo Nordisk. KT declares lecture honoraria and conference travel support from Boehringer Ingelheim. AA, ASA, GR, KL and MP1 declare no competing interests in relation to this article.